Results 191 to 200 of about 1,410,232 (284)
Adiponectin receptor T-cadherin emerges as a novel regulator of adipose stem cell quiescence and adipogenesis. [PDF]
Sysoeva VY +13 more
europepmc +1 more source
The study found that uncarboxylated osteocalcin (unOCN) regulates energy metabolism in postpartum dairy cows by promoting the secretion of adiponectin and glucagon‐like peptide‐1. Furthermore, unOCN acts directly on the liver, activating the hepatic AMPK‐PPARα pathway, which consequently reduces lipid accumulation in the liver.
Zhantao Yang +9 more
wiley +1 more source
Targeting Adiponectin Receptor 1 Phosphorylation Against Ischemic Heart Failure. [PDF]
Zhu D +15 more
europepmc +1 more source
Adiponectin (ADIPOQ); adiponectin receptor 1 (ADIPOR1); ADIPOR2 [PDF]
openaire +1 more source
New‐Onset Type 2 Diabetes Mellitus and Cancer Risk: A Matched Cohort Study in China Kadoorie Biobank
ABSTRACT The prevalence of type 2 diabetes mellitus (T2DM) is rising rapidly in China and is linked to increased cancer risk, but causality remains unclear due to biases. We examined the causal effect of T2DM on cancer risk using bias‐minimizing methods.
Mengying Wang +9 more
wiley +1 more source
Neuroprotection through adiponectin receptor agonist: an updated meta-analysis of preclinical Alzheimer's disease studies. [PDF]
Novinbahador T +5 more
europepmc +1 more source
In vitro and in silico characterization of adiponectin-receptor agonist dipeptides. [PDF]
Lee Y +7 more
europepmc +1 more source
ABSTRACT Aim Metabolic syndrome (MetS) is a known risk factor for hepatocellular carcinoma (HCC), but the impact of cumulative MetS burden and changes in MetS status over time remains unclear. This study aimed to assess these associations using a large‐scale Japanese health dataset.
Yutaka Yata +9 more
wiley +1 more source
Adiponectin receptor agonist, AdipoRon, restores hepatic clock gene expression in PCOS-associated NAFLD. [PDF]
Sharma S, Kabeer SW, Kumar V, Tikoo K.
europepmc +1 more source
ABSTRACT Objective Given the overlap between obesity‐related metabolic and vascular abnormalities and Alzheimer's disease (AD) risk factors, it is critical to determine whether weight loss improves brain and cardiovascular health. This study examined whether ≥ 40% excess‐weight loss is associated with improvements in cardiometabolic risk, brain ...
Naomi L. Gaggi +13 more
wiley +1 more source

